The Chinese pharmaceutical giant Sinopharm, which develops a vaccine against the coronavirus, has ensured that it has already supplied the product to around one million people in the Asian country, without serious side effects being detected for now.
The president of the company, Liu Jingzhen, has assured that to date “only a few” people have shown “mild symptoms” after receiving the vaccine, according to a statement posted by Sinopharm on Wechat.
Vaccination is framed within a emergency program With which Beijing would have already begun to immunize strategic sectors. The official media have been reporting vaccinations to health workers, military, diplomats and other officials.
Sinopharm vaccine has already completed phase three trials following work carried out in a total of ten countries, including the United Arab Emirates, Bahrain, Egypt, Jordan, Peru and Argentina.